2279 — Yonghe Medical Co Cashflow Statement
0.000.00%
- HK$514.77m
- HK$705.07m
- CNY1.80bn
- 57
- 74
- 36
- 60
Annual cashflow statement for Yonghe Medical Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 231 | 210 | -109 | -585 | — |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 47.1 | 47 | -51.9 | 132 | — |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 64.4 | -20.9 | -172 | 102 | 229 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 502 | 437 | -109 | -17.2 | 229 |
Capital Expenditures | -143 | -191 | -244 | -171 | — |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0.459 | -3.3 | -407 | 417 | -53.3 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -142 | -194 | -651 | 246 | -53.3 |
Financing Cash Flow Items | -4.87 | 1,092 | -33.9 | -2.34 | -291 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -156 | 1,028 | -333 | -185 | -291 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 203 | 1,273 | -1,001 | 38.1 | -115 |